stride trial semaglutide study What were the key findings and safety outcomes of the evaluating in Expanding cardiovascular indications for semaglutide:

2 Now WeightWatchers Clinic also ensures individuals have access to greater support with FDA-approved clinical interventions, if interested and deemed medically appropriate in an offering that provides the best of biological and behavioral approaches To educate and excite both current and prospective WeightWatchers members on the new GLP-1 Program and WeightWatchers Clinic, the Company will be offering multiple consumer touch points across various U.S

PubMed Bendich A, Cohen M

But not everyone should be taking these drugs, which can have serious side effects, including bowel obstruction, gallstone attacks and pancreatitis

Both are part of a booming class of medications often grouped under the umbrella of GLP-1 drugs, which roughly 12% of Americans including about 1 in 5 women over 50 have used for weight loss or diabetes management